| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| 201096-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-叔丁基苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C41H47O4P | |
| 201096-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-叔丁基苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C41H47O4P | |
| 201095-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(1-芘基)螺环二酚磷酸酯 (11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C53H39O4P | |
| 201095-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(1-芘基)螺环二酚磷酸酯 (11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C53H39O4P | |
| 201095-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(1-芘基)螺环二酚磷酸酯 (11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C53H39O4P | |
| 201094-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(1-芘基)螺环二酚磷酸酯 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C53H39O4P | |
| 201094-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(1-芘基)螺环二酚磷酸酯 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C53H39O4P | |
| 201094-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(1-芘基)螺环二酚磷酸酯 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C53H39O4P | |
| 201093-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(4-氯苯基)螺环二酚磷酸酯 (11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C33H29Cl2O4P | |
| 201093-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(4-氯苯基)螺环二酚磷酸酯 (11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C33H29Cl2O4P | |
| 201093-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(4-氯苯基)螺环二酚磷酸酯 (11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C33H29Cl2O4P | |
| 201092-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-氯苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C33H29Cl2O4P | |
| 201092-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-氯苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C33H29Cl2O4P | |
| 201092-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-氯苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C33H29Cl2O4P | |
| 201091-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(9-菲基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C49H39O4P | |
| 201091-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(9-菲基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C49H39O4P | |
| 201091-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(9-菲基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C49H39O4P | |
| 201090-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(9-菲基)螺环二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C49H39O4P | |
| 201090-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(9-菲基)螺环二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C49H39O4P | |
| 201090-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(9-菲基)螺环二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C49H39O4P | |
小泰
|
010-60710855
|